Opening of the Radspherin® Production and Laboratory Facility

STOCKHOLM, Dec. 13, 2017 /PRNewswire/ --

Oncoinvent held an opening ceremony for its new production and lab facilities today.  A total of 40 guests attended the opening. 

The new production facility contains a dedicated Grade B clean room, two Category B type isotope production suites, a quality control laboratory, and packaging area that will support qualified operations for manufacturing, analytical control, packaging and labelling of Radspherin® for upcoming preclinical and clinical studies.

Jan A. Alfheim, Oncoinvent's CEO commented: "This event marks a highlight in a year that has seen tremendous growth in  the company.  The opening of our new laboratory and production facilities represents a significant achievement for the company and will enable the company to move Radspherin® rapidly into the next phase of development in 2018." 

For further information, please contact:

Jan A. Alfheim, Chief Executive Officer
Cell: +47-46-44-00-45
Email: alfheim@oncoinvent.com

IR enquiries:
Ole Peter Nordby, Chief Financial Officer 
Cell: +47-41-28-71-79 
Email: nordby@oncoinvent.com

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/oncoinvent-as/r/opening-of-the-radspherin---production-and-laboratory-facility,c2413815

The following files are available for download: